Psychological Phenomena

31 trials 16 recruiting

Filter these 31 trials by phase, country and sponsor.

Open in Search →

Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin a… Not authorised

2023-505253-41-00 Autism Spectrum Disorder (ASD) 5
Psilocybin's effects on anhedonia Not authorised

2023-509009-59-00 Major Depressive Disorder 3
Pharmacological treatment of compulsive sexual behaviour disorder Not authorised

2024-514490-22-00 Compulsive Sexual Behaviour Disorder 5
A Randomized, Delayed-Treatment Controlled, Phase 2 Pilot Study of Manualized MDMA-Assisted Therapy for Young Adults with Chronic Treatment-… Pending

2024-520319-42-01 Major Depressive Disorder 4
Propranolol for early secondary prevention of post-traumatic stress disorder in female victims of sexual violence: a single-center, randomiz… Pending

2023-504075-25-00 Prevention of post-traumatic stress disorder 4
SEDICAN: Sex differences in the acute effects of cannabis Pending

2023-505159-35-00 N/A - healthy volunteers 3
Exploring the Psychoactive Effects of Paracetamol: A Randomized Controlled Trial. Pending

2025-522753-19-02 Healthy adults aged 18-30. 6
Intranasal oxytocin in youth with autism Pending

2024-512387-56-00 Autism spectrum disorder 4
The therapeutic potential of psilocybin in anorexia nervosa in young adults Pending

2024-515163-63-00 Anorexia Nervosa 4
Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET) Pending

2025-521330-29-00 Major Depression Disorder (MDD) 4
Role of the noradrenergic system in the regulation of learning dynamics: evaluation of the effect of a low-dose selective noradrenaline reup… Recruiting

2025-520959-90-00 Healthy subjects with no neurological or psychiatric di 4 2025-11-18
Exploring the mechanistic link between the oxytocinergic system and mindfulness training Recruiting

2024-513482-39-00 Psychological distress complaints 4 2025-05-15
PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity_PHACYLOB. Recruiting

2024-519461-22-00 Attention Deficit Disorder with or without Hyperactivit 6 2026-03-30
A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disorders evaluating neural plastici… Recruiting

2023-506826-36-00 Autism spectrum disorder 4 2026-01-26
Psilocybin's effects on anhedonia Recruiting

2024-519265-22-00 Major Depressive Disorder 3 2025-11-12
Oxytocin and attachment development: Looking beyond the expected? Recruiting

2024-518004-49-00 Healthy children 9 2025-10-28
A study to assess the efficacy and safety of ITI-1284 in the treatment of Agitation Associated with Alzheimer's Dementia Recruiting

2024-514680-26-00 Agitation Associated with Alzheimer’s Dementia 4 2025-07-17
Pharmacological treatment of compulsive sexual behaviour disorder Recruiting

2024-514490-22-01 Compulsive Sexual Behaviour Disorder 5 2025-06-12
PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients Recruiting

2023-510488-36-01 Chronic obstructive pulmonary disease (COPD), amyotroph 4 2025-06-01
Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote) Recruiting

2023-506329-12-00 Treatment of suicidal ideation 4 2025-05-14
Randomized Clinical Trial on Oxytocin and Self-Compassion Training in Borderline Personality Disorder Recruiting

2024-515589-15-00 Borderline Personality Disorder. 6 2024-07-25
CBD-OH - Cannabidiol as an add-on treatment during inpatient alcohol cessation in patients with severe alcohol use disorder: a Phase II tria… Recruiting

2024-518455-28-00 Patients with severe Alcohol Use Disorder (according to 4 2024-07-03
Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin a… Recruiting

2023-505253-41-01 Autism Spectrum Disorder (ASD) 5 2024-06-18
Psilocybin for hospitalized patients with treatment-resistant depression Recruiting

2022-501857-35-00 treatment-resistant depression 4 2024-04-22